Wimmel A - Search Results

1

Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.

Risse-Hackl G, Adamkiewicz J, Wimmel A, Schuermann M. Risse-Hackl G, et al. Among authors: wimmel a. Oncogene. 1998 Jun 11;16(23):3057-68. doi: 10.1038/sj.onc.1201845. Oncogene. 1998. PMID: 9662339

2

In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways.

Kraus AC, Ferber I, Bachmann SO, Specht H, Wimmel A, Gross MW, Schlegel J, Suske G, Schuermann M. Kraus AC, et al. Among authors: wimmel a. Oncogene. 2002 Dec 12;21(57):8683-95. doi: 10.1038/sj.onc.1205939. Oncogene. 2002. PMID: 12483521

3

Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E.

Wimmel A, Lucibello FC, Sewing A, Adolph S, Müller R. Wimmel A, et al. Oncogene. 1994 Mar;9(3):995-7. Oncogene. 1994. PMID: 8108147

4

Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion.

Wimmel A, Glitz D, Kraus A, Roeder J, Schuermann M. Wimmel A, et al. Eur J Cancer. 2001 Nov;37(17):2264-74. doi: 10.1016/s0959-8049(01)00271-4. Eur J Cancer. 2001. PMID: 11677117

5

Transition from suspension to adherent growth is accompanied by tissue factor expression and matrix metalloproteinase secretion in a small cell lung cancer cell line.

Salge U, Seitz R, Wimmel A, Schuermann M, Daubner E, Heiden M. Salge U, et al. Among authors: wimmel a. J Cancer Res Clin Oncol. 2001 Feb;127(2):139-41. doi: 10.1007/s004320000210. J Cancer Res Clin Oncol. 2001. PMID: 11216916

6

Preferential histiotypic expression of CD44-isoforms in human lung cancer.

Wimmel A, Schilli M, Kaiser U, Havemann K, Ramaswamy A, Branscheid D, Kogan E, Schuermann M. Wimmel A, et al. Lung Cancer. 1997 Mar;16(2-3):151-72. doi: 10.1016/s0169-5002(96)00625-3. Lung Cancer. 1997. PMID: 9152947

7

Synthesis and secretion of the anticoagulant protein S and coexpression of the Tyro3 receptor in human lung carcinoma cells.

Wimmel A, Rohner I, Ramaswamy A, Heidtmann HH, Seitz R, Kraus M, Schuermann M. Wimmel A, et al. Cancer. 1999 Jul 1;86(1):43-9. doi: 10.1002/(sici)1097-0142(19990701)86:1<43::aid-cncr8>3.0.co;2-d. Cancer. 1999. PMID: 10391562

8

Tumor suppressor p16INK4a controls oncogenic K-Ras function in human pancreatic cancer cells.

Rabien A, Sanchez-Ruderisch H, Schulz P, Otto N, Wimmel A, Wiedenmann B, Detjen KM. Rabien A, et al. Among authors: wimmel a. Cancer Sci. 2012 Feb;103(2):169-75. doi: 10.1111/j.1349-7006.2011.02140.x. Epub 2011 Dec 15. Cancer Sci. 2012. PMID: 22049925 Free article.

9

Variant expression of CD44 in preneoplastic lesions of the lung.

Wimmel A, Kogan E, Ramaswamy A, Schuermann M. Wimmel A, et al. Cancer. 2001 Sep 1;92(5):1231-6. doi: 10.1002/1097-0142(20010901)92:5<1231::aid-cncr1442>3.0.co;2-z. Cancer. 2001. PMID: 11571737

10

Tumor suppressor p16 INK4a: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model.

Sanchez-Ruderisch H, Fischer C, Detjen KM, Welzel M, Wimmel A, Manning JC, André S, Gabius HJ. Sanchez-Ruderisch H, et al. Among authors: wimmel a. FEBS J. 2010 Sep;277(17):3552-63. doi: 10.1111/j.1742-4658.2010.07764.x. Epub 2010 Jul 31. FEBS J. 2010. PMID: 20695889 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results